Acunetix receives highest score for “Penetration Testing” Use Case

Gartner’s 2017 Critical Capabilities for Application Security Testing Report

Gartner, Inc., the leading provider of research and analysis on the global information technology industry, has recognised Acunetix as a Challenger in February 2017 Magic Quadrant for Application Security Testing (AST), and has given Acunetix the highest score out of 18 AST solution providers, in the Penetration Testing Use Case, with a score of 4.52 out of 5.0.

The findings for Gartner’s Critical Capabilities for Application Security Testing were published by Dionisio Zumerle and Ayal Tirosh on March 21, 2017. In the report, the analysts evaluated 18 AST solution providers in five use cases with nine critical capabilities, delivering a comprehensive summary of each provider’s strengths and weaknesses.

We believe the scores Acunetix achieved is testament that Acunetix provides a holistic web security scanning solution. Acunetix saves time by accurately and automatically crawling and scanning web applications for hundreds of different vulnerabilities. In addition, the pen-tester (security consultant) can complement the Acunetix Scan using the manual testing tools provided for everyone to download for free.

Our Magic Quadrant positioning and Critical Capabilities scores reaffirms Acunetix’ position as a pioneer in the application security space with its advanced technology. With applications and their data increasingly targeted by hackers, web application security testing is crucial to eliminate vulnerabilities in the software development life cycle before it hits production.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.